Plasma fractionation is a process of separating various components of plasma. It is used in in prevention and treatment of life threatening diseases caused by trauma, immunologic disorders, and infections. Plasma fractionation process is used in treating protein deficiency in healthcare applications. It is also used in production of packaging material for industrial applications. The removal or inactivation of viruses and prions is a prime function of plasma fractionation.
Increasing use of immunoglobulin in therapeutic areas and prevalence of emphysema & AATD are factors fueling the growth of the world plasma fractionation market. However, high cost, limited reimbursement, and stringent government regulations obstruct growth of the market. On the other hand, increasing number of hemophilic patients are creating opportunities for growth.
The world plasma fractionation market is segmented based on product, application, end user, and geography. On the basis of products, the market is classified into albumin, immunoglobulins, coagulation factor concentrates, and others. The immunoglobulin segment is further classified into subcutaneous immunoglobulin (SCIg), intravenous immunoglobulin (IVIg), and others. Coagulation factor concentrates are divided into factor VIII, factor IX, factor XIII, Von Willebrand factor, prothrombin coagulation concentrates, and fibrinogen concentrates. Applications included in the report are neurology, hematology, immunology, critical care, and others. End users covered in the report are hospitals and clinical research laboratories. Geographically, the market is divided into North America, Europe, Asia-Pacific, and Latin America, Middle East and Africa (LAMEA).
The prominent companies operating in the market are Grifols SA, Baxter International Inc., CSL Ltd., Bio Product Laboratory, Octapharma AG, Sanquin, Laboratoire Franais du Fractionnement et des Biotechnologies, Kedrion, and Biotest. Partnerships, collaborations, mergers & acquisitions, agreements, expansions, joint ventures, and others are some of the key strategies adopted by these prominent manufacturers to strengthen their position in the market.
KEY BENEFITS FOR STAKEHOLDERS:
KEY MARKET SEGMENTS:
Key Market Players:
SIMILAR MARKET STUDIES
2016 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Isothermal Nucleic Acid Amplification Technology (INAAT) industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, ...
May 2016 | $2850 | View Details >>
The United States Nanoparticles Instrumentation Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Nanoparticles Instrumentation industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Nanoparticles Instrumentation market analysis is provided for the ...
June 2016 | $3800 | View Details >>
This new report from VPGMarketResearch.com contains 897 pages, 74 tables, and presents a comprehensive analysis of the German hospital infectious disease testing market, including:
November 2016 | $0 | View Details >>
The North America Respiratory Disease Testing Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Respiratory Disease Testing industry. The report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Respiratory Disease Testing market analysis is ...
April 2016 | $3800 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research